An Injury That Resembles Another

A diagnosis is not only a description. It determines what treatment follows, what a person is told about their prospects, and what those around them believe is happening.

When two conditions present with substantially the same symptoms, and one is common in a population while the other is rarely considered, the clinical outcome is predictable. This article examines what happens when the familiar diagnosis is the wrong one.

The overlap Contested framework

The framework describing chronic quinoline encephalopathy holds that the condition may mimic several psychiatric and neurologic disorders, including PTSD and traumatic brain injury. This is Dr Remington Nevin's formulation, and it carries the disclosure noted in the previous article: Nevin is the framework's principal proponent and has served as a consultant and expert witness in litigation involving anti-malarial toxicity.

Nightmares, insomnia, anxiety, cognitive dysfunction, hypervigilance — every one of these is consistent with PTSD. Every one is also consistent with the proposed presentation of quinoline injury. No symptom on the list discriminates between the two.

Why the default matters

PTSD is common in deployed populations, well characterised, and has established treatment pathways. Quinoline injury is not in diagnostic manuals and requires knowing to ask about a medication taken years earlier.

A family told that a person has PTSD understands the changed behaviour one way. If the injury is neurological and untreated, that explanation will not fit what they observe — and will not fit for years.

The Australian context Documented

Nearly 3,000 Australian Defence Force personnel took part in Army Malaria Institute trials of tafenoquine and mefloquine, including a mefloquine-versus-tafenoquine study in East Timor during 2000–2002. The Australian Senate's 2018 inquiry stated it was not composed of health experts and could not make findings on medical causation.

Two necessary qualifications Unconfirmed

If two conditions cannot be distinguished by symptoms, a claim that one was mistaken for the other cannot be verified by symptoms either. And human neurohistopathological testing of tafenoquine has never been performed — an absence of evidence, not a finding either way.

For this series, the relevant consequence is domestic. A household living alongside an untreated injury operates on whatever explanation it has been given. If that explanation is wrong, the household's understanding of what is happening is wrong with it, for as long as the misattribution stands.